Biomarkers in Vascular Ehlers-Danlos Syndrome

Key facts

Sponsor

Assistance Publique - Hôpitaux de Paris

Principal Investigator

Michael Frank, MD

Centre de Reference des Maladies Vasculaires Rares, Hopital Europeen Georges Pompidou, APHP, Paris France

Enrollment

211 enrolled

Eligibility

18-70 years · All sexes

Timeline

2013 – 2015

Study locations (1)

• Hopital europeen Georges Pompidou, Paris, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Vascular Ehlers-Danlos syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT05994664
  Heart Coherence Training on Vascular Ehlers-Danlos Syndrome Patients
  Baylor College of Medicine
• RECRUITINGPHASE3NCT05432466
  Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
  Acer Therapeutics Inc.

See all trials for Vascular Ehlers-Danlos syndrome →